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Abstract
Background and Objective: Neural Tube Defect (NTD) is the leading cause of death in infants younger than one year. Incidence of
congenital anomalies has approximately 1 in 1000 live births in the United States. Less dietary folic acid and vitamin B12 in the mother
during the critical period of pregnancy reported to play a role in the occurrence of neural tube defects. The aim of this study was
compared  the level of folic acid and vitamin B12 in both mother and her child with and without NTD.  Methodology:  This study was
cross-sectional design and will be examined levels of folic acid in six mothers and children with and without neural tube defect in Saiful
Anwar  Hospital  during  September, 2009  until  September, 2013.  Results: This  study  showed no significant differences of folic acid
and vitamin B12 level between NTD and control group in mothers (p>0.05). The study also showed no significant differences of folic acid
and  vitamin  B12  level  between  NTD  group  and  control group in children (p>0.05). Conclusion:  The level of folic acid and vitamin
B12 in the mother having neural tube defect child as much as the mother with haven’t neural tube defect child. Additionally, the result
of the children above a year with neural tube defect and without neural tube defect has same folic acid and vitamin B12 level.
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INTRODUCTION
Neural Tube Defect (NTD) is the terminology that used to
encompass all clinical variation for not closing neural tube1.
This malformation can results disorder on brain and spinal
cord2, affecting 0.5-2 per 1000 established pregnancies3 , with
the sex ratio (males: females) was4 0.73 and severe NTD have
a 15-fold increased risk of death during the first year of life5.
Neural tube is formed in the third and fourth weeks of fetal
age6. The spinal cord forms early in embryonic stems from the
region that is the flat area, which will then be rotated to form
the neural tube when the fetus is 28 days old. If the neural
tube does not close completely, then formed NTD. Neural tube
defects are created when most women do not realize that she
was pregnant7.
The main flaw is the failure of neural folds fused in the
midline. Then form the neural tube, called neuroectoderm.
The next defect is a deviation in the formation of the
mesoderm, which, in turn, forming the structure of bones and
muscles that cover the underlying neural structures1. The
central nervous system occurs in the third week of embryonic,
shaped like a shoe-shaped plate ectoderm thickening, called
the neural plate. The plates were located in the dorsal region,
in the middle and front blastoporus. The lateral edges of these
plates immediately rise to form two neural fold8.
In further development, neural folds increasing, each
approaching the halfway line and eventually united, thus
forming the neural tube (neural tube). Unification began on
the neck, take place towards the cephalic and caudal with an
irregular pattern. At the end of the caudal and cranial fetus,
the unification somewhat delayed, so neuroporus anterior and
posterior to temporarily connect with a neural tube cavity
amniotic cavity. Neuroporus anterior closure occurred on the
25th day of embryonic life, while the posterior neuroporus
closed approximately two days later1,8,9. Failure closing the
posterior neuroporus cause spina bifida, while failure of neural
tube closure of the anterior portion causes anencephaly,
eksensefalus, encephalocele or meningocele9,10.
The cells of the neural plate and induction
neuroectoderm prepare them to introduce what is called a
neurulation process. Induction of cells is a complex process,
involving the stimulation of a group of cells of the surrounding
tissue. This process occurs repeatedly during organogenesis.
Signals from the various processes and genes that regulate
these events are still not clearly known. Various signaling
molecules believed to be members of the superfamily of
Transforming Growth Factor-$ (TGF-$) including activin and
Fibroblast Growth Factor (FGF)1.
Neural tube defect is the leading cause of death in infants
less than one year of age. The incidence of congenital
anomalies has approximately 1 in 1000 live births in the
United States. This defect is the second highest birth
deformities after congenital heart defects6. The incidence of
meningocele is 1-2 in 1000 live birth in South East Asia and the
frequency of this clinical variation is eight until nine percent in
Malang and Surabaya11.The etiologies of NTD are nutrition,
teratogen and genetic12.
Some chromosomal and single-gene disorders have been
associated with NTD. Spina bifida occurs more often in
autosomal trisomy. Studies in animals show that there are 100
mutant genes that affect neurulation and almost all of them
have homologs in humans13. The experimental studies on NTD
provide some evidence that the number of physical agents
(example X-ray radiation, hyperthermia, stress), drugs
(example thalidomide, folic antagonists androgenic hormone,
anti-epileptics such as valproate and carbamazepine and
hypervitaminosis A), alcohol abuse, substance chemistry
(example organic mercury, lead), maternal infections (such as
rubella, cytomegalovirus, toxoplasma gondii, syphilis),
metabolic conditions mom (example phenylketonuria,
diabetes mellitus, cretinism endemic), capable of causing
congenital malformations of the structure of the central
nervous system14,15.
Folic acid deficiency during conception until the end of
the third month of pregnancy is believed to play a most
important factor in NTD. Has observed that Transforming
Growth Factor-$ (TGF-$1) and Insulin-like Growth Factor-1
(IGF-1) play an important role in supporting bone formation.
Therefore, folic acid deficiency can cause neural tube defects
by decreasing the expression of TGF-$1 and IGF-111.
Folic acid has three physiological effects; first, as a
cofactor to enzymes that synthesize DNA and RNA; second, it
is necessary for the conversion of homocysteine to methionine
and third, it is necessary for the methylation process in the
formation of proteins. During the early formation of the fetus,
the synthesis of nucleic acids and proteins are in peak
condition and during this period maternal folate requirements
increase sharply. When folate is insufficient, nucleic acid
inhibited and cells are not able to facilitate DNA for mitosis.
Cycle inhibition also resulted in the inability of DNA
methylation and m-RNA of cells to synthesize amino acids and
proteins including TGF-$1 and IGF-111,16.
This research examined folic acid and vitamin B12 levels
of 6 mothers and children with NTD that has been hospitalized
in Saiful Anwar Hospital Malang between September 2009
until 2013, compared with six mothers and children without
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NTD. The folic acid and vitamin B12 levels are measured in
Prodia Laboratory. Furthermore, the teratogen and genetic
data is evaluated by history taking. 
MATERIALS AND METHODS
This study was an observational cross-sectional approach
and the data was taken from the patient's medical record in
Saiful Anwar Hospital from September 2009 to September
2013 (3 years). This study examined folic acid and vitamin B12
levels in 6 mothers and children with neural tube defect. The
results compared with six moms and children without NTD.
The inclusion criteria were the subjects approved to be
participated in this study and supported by signing the
informed consent. The exclusion criteria were the subject of
the study did not receive a blood transfusion within two
months. The range of age for the mother is from 20 years old
until 45 years old, for the children is from 1 years old until 6
years old.
The other etiology factors of NTD, teratogen and genetic,
were asked to the subject using questioner. The teratogen
factors include consumption of phenytoin, salicylate, alcohol,
X-ray and fungal infection. In addition, the genetic factor is
examined by comparing five generation’s pedigree of subjects
and controls.
RESULTS AND DISCUSSION
Table 1 shows that the mother who has a child with and
without  NTD  has  folic  acid  and  vitamin  B12  level  above
the   minimum    range.     The   normal   range   is  between
7.2-19.4 ng mLG1 for folic acid and 211-911 pg mLG1 for vitamin
B12 level. From the teratogen factors were asked using
questioner  and   no   mothers   were   exposed   to  teratogen. 
Moreover, the genetic factor was illustrated in 5 pedigrees
generation and no one has a history of NTD before.
Researchers generally agree that nutritional factors are
the most important etiology of neural tube defects. Less
dietary folic acid in the mother during the critical period of
pregnancy reported to play a role in the occurrence of neural
tube defects. Approximately 70% of cases of neural tube
defects can be prevented by administration of vitamin
supplements16-18.
The function of folic acid is to transfer one unit carbon in
metabolism. That carbon is used in metabolic amino acid and
biosynthetic purine-pyrimidine from nucleate acid. Folic acid
will accelerate the separation of the cell during the closure of
neural tube19. The vitamin B12 converse 5 mTHF to THF, which
used to synthesize purine and thymine for DNA replication20.
The age of the mother during pregnancy, too young and too
old (more than 40 years old) can be a risk factor for NTD21. In
this case report, the result odd ratio 2.5, 95% confidence
interval = 0.2-87 (OR>1) so that age more than 40 years old
can be a risk factor for NTD (Table 2).
Table 2 shows that children with and without NTD had
folic acid and vitamin B12 levels above the minimum range
5.5-15.5 ng mLG1 and 211-911 pg mLG1. The pattern of eating
from both groups were asked by the questioner and we got
that the consumption patterns among children with and
without  NTD  have  relatively  similar  tendencies, which was
4-5 perfectly healthy meal.
Furthermore, the folic acid and vitamin B12 status of
children with and without neural tube defect produce t-test
statistic  0.382   with   probability   equal  to 0.711, while
vitamin B12 produce t-test statistic 1.115 with probability
equal to 0.305.  The  results  of  these  tests indicate the
probability>level of significance (" = 5%), thus it can be stated
that the examination   of   children   with  neural  tube   defects
Table 1: Characteristics of the mother
Mother who has a child with NTD Mother who has a child without NTD
---------------------------------------------------------------------------------- ----------------------------------------------------------------------------------
Age (years) <30 30.1-35 35.1-40 >40 <30 30.1-35 35.1-40 >40
Percentage 50 0 16.67 33.33 50 0 16.67 33.33
Nutritional factors
Folic acid (ng mLG1) 16.3 - 25 13.2 15.6 - 18.17 13.42
Vitamin B12 (pg mLG1) 534 - 291 638 599 - 768 633
Teratogen factors
Phenytoin N/A N/A N/A N/A N/A N/A N/A N/A
Salicylate N/A N/A N/A N/A N/A N/A N/A N/A
Alcohol N/A N/A N/A N/A N/A N/A N/A N/A
X-ray N/A N/A N/A N/A N/A N/A N/A N/A
Fungal infection N/A N/A N/A N/A N/A N/A N/A N/A
Genetic factor
In heritage 5* 5* 5* 5* 5* 5* 5* 5*
5*: From pedigree 5 generation, there wasn’t history of neural tube defect, N/A: From questioner results, there wasn’t history of exposure the teratogen during
pregnancy, NTD: Neural tube defect
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Table 2: Characteristics of the children
Children with NTD Children without NTD
------------------------------------------------------------------------------- ---------------------------------------------------------- ---------------------
Age (years) 1-2 2.1-4 4.1-6 >6 1-2 2.1- 4 4.1-6 >6
Percentage 33.33 16.67 33.33 16.67 33.3 16.67 33.33 16.67
Folic acid (ng mLG1) 25.7 27.4 24.85 16.3 22.23 26.48 21.98 18.79
Vitamin B12 (pg mLG1) 677 944 609 364 890.5 913 768 757
NTD: Neural tube defect
Table 3: Different test of folic acid and vitamin B12 to NTD using the t-test
t-test for equality of means
----------------------------------------------------------------------------
T df Sig. (2-tailed) Mean Difference
Mothers
Vitamin B12 1.313 10 0.218 154.5
Folic acid -0.153 10 0.881 -0.34833
Children
Vitamin B12 1.115 6.43 0.305 149.5
Folic acid 0.382 10 0.711 1.615
Sig: Significant
and  without  neural  tube  defect  produce the same level of
folic acid and vitamin B12 (Table 3).
Results from five case-control studies to investigate the
relationship between folic acid supplementation in pregnant
women with NTD births have been reported in 1988 and 1995.
The study, conducted using a population of women with no
previous NTD pregnancy and folic acid supplements before
conception and then continued in the first week pregnancy;
in some maternal and child health agencies. Mulinare et al.22
in studies in Atlanta, GA, found 0.8 mg of folic acid associated
with 60% decreased risk of NTD cases.
 Bower and Stanley23 evaluated the cases of spina bifida in
Western Australia, reported a high intake of folate is used
related to a reduced risk of neural tube defects by 75%.
Instead, Mills et al. 24 found that there was no protective effect
of folate intake is 0.8 mg through a case control study in
California and Illinois. However, Werler et al.25 in Boston,
Philadhelphia and Toronto, showed a reduction of the
provision of multivitamin related to decreased risk of NTD by
40% and Shaw et al.26 in California, respectively, showed that
with the addition of a multivitamin containing folic acid before
conception is associated with decreased risk of NTD by 35%
Shaw et al.26. Thus, the conclusion of four of the five
retrospective studies showed a statistically significant
reduction in the risk of NTD between 35 -75%, while one study
found that the effect is not clear.
 The role of maternal nutrition on fetal development has
been widely known. Nutritional status of the parents can affect
the quality of gametes and fertilization capacity. There are
several reports that prove the enzyme metabolize
polymorfisime fertilization may be associated with meiotic
non-disjunction in the embryo27. From the observation that 
folic acid consumption before conception provide beneficial
effects by lowering the incidence of neural tube defects as
much  as  50-70%28  and  reduction  in  NTD incidence
increases  with  folic  acid.  As  a  result,  the amount of folic
acid associated with the gene has  been  studied  in  great
detail. The  following  genes  are  involved  in the metabolism
of folate that 5,10-methylene tetrahydrofolate reductase
(MTHFR), methylene tetrahydrofolate dehydrogenase
(MTHFD), cystathionine $-synthase (CBS), methionine synthase
(MTR), methionine synthase reductase (MTRR) and folate
receptor " and $.
CONCLUSION
The results showed that folic acid and vitamin B12 of6
mothers who has children with neural tube defect and
without neural tube defect had the same level. Additionally,
the results of 6 children above a year with neural tube defect
and without neural tube defect folic acid and vitamin B12
showed the same degree. The subjects are taken from
SaifulAnwar Hospital from September 2009 until September
2013.
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